Literature DB >> 16861492

Dapsone therapy for Henoch-Schonlein purpura.

J I Shin, J S Lee, K S Chung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16861492      PMCID： PMC2083057     

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  3 in total

1.  Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura.

Authors:  Hitomi Sano; Michiko Izumida; Hiroshi Shimizu; Yunosuke Ogawa
Journal:  Eur J Pediatr       Date:  2002-04       Impact factor: 3.183

2.  Dapsone therapy for Henoch-Schönlein purpura: a case series.

Authors:  H Iqbal; A Evans
Journal:  Arch Dis Child       Date:  2005-09       Impact factor: 3.791

3.  Predictive factors of renal involvement or relapsing disease in children with Henoch-Schönlein purpura.

Authors:  Donato Rigante; Marcello Candelli; Gilda Federico; Francesco Bartolozzi; Maria Grazia Porri; Achille Stabile
Journal:  Rheumatol Int       Date:  2004-03-06       Impact factor: 2.631
  3 in total
  2 in total

Review 1.  Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature.

Authors:  Céline Roman; Bogdan Dima; Laurence Muyshont; Thierry Schurmans; Olivier Gilliaux
Journal:  Eur J Pediatr       Date:  2019-06-22       Impact factor: 3.183

2.  Dapsone in immunoglobulin A-associated vasculitis.

Authors:  Vera Ramelli; Pietro O Rinoldi; Mario G Bianchetti; Sebastiano A G Lava; Gian Paolo Ramelli; Gregorio P Milani
Journal:  Eur J Pediatr       Date:  2019-10-19       Impact factor: 3.183
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.